Cynthia Bernier

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Obatoclax is a clinical stage drug candidate that has been proposed to target and inhibit prosurvival members of the Bcl-2 family, and thereby contribute to cancer cell lethality. The insolubility of this compound, however, has precluded the use of many classical drug-target interaction assays for its study. Thus, a direct demonstration of the proposed(More)
  • 1